Title : Lenalidomide restrains motility and overangiogenic potential of bone marrow endothelial cells in patients with active multiple myeloma.

Pub. Date : 2011 Apr 1

PMID : 21307145






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Lenalidomide-treated MMECs showed changes in VEGF/VEGFR2 signaling pathway and several proteins controlling EC motility, cytoskeleton remodeling, and energy metabolism pathways. Lenalidomide vascular endothelial growth factor A Homo sapiens